Cite Filings / CRSP / 0001950047-24-002408
Feed Companies Filings Check
Sign in
144

Sale of Securities

CRISPR Therapeutics AG · Filed 2024-03-15 · Acc 0001950047-24-002408

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2024-03-22 144 Sale of Securities
  • 2024-03-18 4 Chief Financial Officer sold 3,524 shares at $72.69 ($256,160)
  • 2024-03-18 4 Chief Executive Officer sold 20,000 shares at an average $72.48 ($1,449,628)
  • 2024-03-15 144 Sale of Securities
  • 2024-03-12 4 General Counsel and Secretary sold 3,947 shares at an average $77.15 ($304,515)
  • 2024-03-12 4 Chief Executive Officer sold 14,385 shares at an average $77.04 ($1,108,263)
  • 2024-02-15 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…